Trial Profile
A Prospective study to evaluate the efficacy of Varicella Zoster Virus booster vaccine (Zostavax) in patients awaiting renal transplantation and healthy individuals
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2016
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Herpes zoster
- Focus Therapeutic Use
- 10 Nov 2016 New trial record